Robotic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is there a benefit? is a research paper published in Surgical Endoscopy (2024). On theSindex it has a DataRank of 0.269. It has been cited 5 times, with 5 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0
From 0 citing papers with measurable signal
This paper's DataRank is currently driven only by its base citation score. None of the citing papers had measurable citation signal.
Learn more about DataRank methodology →NCI NIH HHS
Grant: U54 CA283762
NCI NIH HHS
Grant: U54 CA233444
NCI NIH HHS
Grant: R01 CA242003
National Institutes of Health
Grant: 1U54CA233444-01
2/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center
National Institutes of Health
Grant: 5R01CA242003-03
Use of BCL-xL Proteolysis targeting chimeras to treat pancreatic cancer
Fields of Study
MeSH Terms
Keywords